Results 161 to 170 of about 132,265 (338)
Dreamm-2: single-agent belantamab mafodotin in patients with relapsed/refractory multiple myeloma (rrmm), including subgroups with renal impairment (ri) and high-risk (hr) cytogenetics
, 2020 Sagar Lonial, H.C. Lee, Ashraf Badros, S. Trudel, Ajay K. Nooka, Ajai Chari, A-O. Abdallah, Natalie S. Callander, Douglas W. Sborov, Attaya Suvannasankha, Katja Weisel, Peter M. Voorhees, Malin Hultcrantz, Edward N. Libby, Paul G. Richardson, Paula Rodríguez‐Otero, Britta Besemer, Thierry Façon, Axel Hoos, January Baron, Trisha Piontek, Roxanne C. Jewell, Erik E. Lewis, Joanna Opalińska, Ira Gupta, Adam D. Cohen, Alice Annalisa Medaglia +26 moreopenalex +1 more sourceHypomethylating agents in vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic syndrome (VEXAS): A systematic review
British Journal of Haematology, EarlyView.Summary
VEXAS syndrome (vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic) is an X‐linked, systemic, haemato‐inflammatory syndrome caused by somatic mutations in the UBA1 gene. No standardized treatment guidelines exist, but evidence is emerging that treatment with hypomethylating agents (HMAs) can induce improvement of the inflammatory symptoms,Fieke W. Hoff, Roochi Trikha, Emma M. Groarke, Bhavisha A. Patel +3 morewiley +1 more sourceIs Less "Sufficient" and "Safe" in the MRD Era - Outcomes of Autologous Stem-Cell Transplant as per Melphalan Dose in Patients with Multiple Myeloma. [PDF]
Blood Cancer JMirgh S, Goel A, Punatar S, Gokarn A, Jindal N, Chichra A, Nayak L, Bain G, Nashikkar C, Mahajan P, Deval K, Khan A, Tembhare P, Patkar N, Rajpal S, Chatterjee G, Kannan S, Mathew L, Subramanian P, Bagal B, Khattry N. +20 moreeuropepmc +1 more sourceSerendipity: Decitabine monotherapy induced complete molecular response in a 77-year-old patient with acute promyelocytic leukemia [PDF]
, 2019 Abboud, Camille N, Abboud, Ramzi, Cashen, Amanda F, DiPersio, John F, Duncavage, Eric J, Han, Se Young, Shirai, Cara Lunn, Welch, John S +7 morecore +3 more sourcesIntegrated genomic analysis to reduce chromosomal analysis for the diagnosis of pediatric hematologic malignancies: addressing the shortage of cytogenetic technologists
Dong Li, Sarah K. Tasian, Gerald Wertheim, Susan R. Rheingold, Kathrin M. Bernt, Haley Newman, Luanne Wainwright, Donna Wilmoth, Brian Thiel, Lea F. Surrey, Elizabeth Margolskee, Vinodh Pillai, Minjie Luo, Michele Paessler, Stephen P. Hunger, Marilyn M. Li, Yiming Zhong +16 moreopenalex +1 more sourcePhase II study of the triple combination of rabbit ATG, ciclosporin and eltrombopag in patients with transfusion‐dependent aplastic anaemia: West Japan Hematology Study Group (W‐JHS) AA02 trial
British Journal of Haematology, EarlyView.Summary
The efficacy of a triple combination of rabbit anti‐human thymocyte immunoglobulin (rATG), ciclosporin and eltrombopag (EPAG) was prospectively evaluated in patients with severe or transfusion‐dependent non‐severe aplastic anaemia (SAA) across 29 institutions in Japan. Sixty patients were enrolled, of whom 48 had SAA. The primary end‐point, the Fumi Nakamura, Ken Ishiyama, Ritsuro Suzuki, Hiroyuki Maruyama, Yasushi Onishi, Kensuke Usuki, Hideo Koh, Katsuto Takenaka, Ryunosuke Saiki, Seishi Ogawa, Kana Matsumoto, Takuto Takahashi, Kazuyoshi Hosomichi, Yoshitaka Zaimoku, Kenichi Yoshimura, Itaru Matsumura, Koichi Akashi, Shinji Nakao +17 morewiley +1 more sourceMachine learning risk stratification strategy for multiple myeloma: Insights from the EMN-HARMONY Alliance platform. [PDF]
HemasphereMosquera Orgueira A, Gonzalez Perez MS, D'Agostino M, Cairns DA, Larocca A, Palacios JJL, Wester R, Bertsch U, Waage A, Zamagni E, Pérez Míguez C, Rojas Martínez JA, Mai EK, Crucitti D, Salwender H, Dall'Olio D, Castellani G, Piñeiro Fiel M, Bringhen S, Zweegman S, Cavo M, Iqbal S, Hernandez Rivas JM, Bruno B, Cook G, Kaiser MF, Goldschmidt H, Van De Donk NWCJ, Jackson G, San-Miguel JF, Boccadoro M, Mateos MV, Sonneveld P. +32 moreeuropepmc +1 more source
